Rilonacept pharmacokinetics in children with systemic juvenile idiopathic arthritis

J Clin Pharmacol. 2015 Jan;55(1):39-44. doi: 10.1002/jcph.372. Epub 2014 Aug 22.
No abstract available

Keywords: interleukin-1 inhibitor; pediatrics; population pharmacokinetics; systemic juvenile idiopathic arthritis.

Publication types

  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adolescent
  • Arthritis, Juvenile / blood*
  • Arthritis, Juvenile / drug therapy
  • Child
  • Child, Preschool
  • Double-Blind Method
  • Female
  • Humans
  • Infant
  • Male
  • Models, Biological*
  • Recombinant Fusion Proteins / blood
  • Recombinant Fusion Proteins / pharmacokinetics*
  • Serum Albumin / analysis

Substances

  • Recombinant Fusion Proteins
  • Serum Albumin
  • rilonacept